Reducing cardiovascular risk in patients with type 2 diabetes mellitus

被引：0
|
作者：
Nicholls, Stephen J. [1 ]
Ryden, Lars [2 ]
机构：
[1] Cleveland Clin, Ctr Cardiovasc Diagnost & Prevent, Dept Cardiovasc Med & Cell Biol, Cleveland, OH 44195 USA
[2] Karolinska Inst, Dept Med, Cardiol Unit, Stockholm, Sweden
来源：
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION | 2010年 / 17卷
关键词：
D O I：
10.1097/01.hjr.0000368716.79219.21
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S1 / S1
页数：1
相关论文
共 50 条
  • [21] Cardiovascular risk of sitagliptin in treating patients with type 2 diabetes mellitus
    Zeng, De-kang
    Xiao, Qian
    Li, Fa-qi
    Tang, Yu-zhi
    Jia, Chao-li
    Tang, Xue-wen
    BIOSCIENCE REPORTS, 2019, 39
  • [22] Assessment of Cardiovascular Risk Factors in Patients With Type 2 Diabetes Mellitus
    Ramona, Dragut R.
    Rusu, Emilia
    Radulian, Gabriela
    Parpala, Cristina
    Popescu, Horatiu
    Nan, Raluca
    DIABETES, 2012, 61 : A562 - A563
  • [23] Empagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk
    Inzucchi, Silvio E.
    Wanner, Christoph
    Lachin, John M.
    Fitchett, David
    Bluhmki, Erich
    Hantel, Stefan
    Mattheus, Michaela
    Devins, Theresa
    Johansen, Odd Erik
    Woerle, Hans Juergen
    Broedl, Uli C.
    Zinman, Bernard
    CIRCULATION, 2015, 132 (23) : 2271 - 2271
  • [24] Cardiovascular risk factors in patients of type 2 diabetes mellitus with and without cardiovascular complications
    Aasvee, KE
    Kurvinen, E
    Roovere, T
    Tupits, H
    Hedman, A
    Jauhiainen, M
    Sundvall, J
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 152 - 152
  • [25] Thiazolidinedione and cardiovascular risk in type 2 diabetes mellitus
    Yenny
    UNIVERSA MEDICINA, 2008, 27 (04) : 183 - 193
  • [26] Type 2 diabetes and cardiovascular disease: Reducing the risk
    Bartels, David W.
    Davidson, Michael H.
    Gong, William C.
    JOURNAL OF MANAGED CARE PHARMACY, 2007, 13 (02): : S2 - S15
  • [27] Cardiovascular risk assessment in type 2 diabetes mellitus
    Ebaa Al-Ozairi
    R. Jan-Willem Middelbeek
    Edward S. Horton
    Current Diabetes Reports, 2006, 6 (5)
  • [28] Type 2 diabetes mellitus is not a cardiovascular risk equivalent
    Saely, CH
    Marte, T
    Aczel, S
    Langer, P
    Koch, L
    Schmid, F
    Drexel, H
    DIABETES, 2005, 54 : A182 - A183
  • [29] Cardiovascular risk in the spectrum of type 2 diabetes mellitus
    Ahmed, Intekhab
    Goldstein, Barry J.
    MOUNT SINAI JOURNAL OF MEDICINE, 2006, 73 (05): : 759 - 768
  • [30] Reducing high risk of cardiovascular events in Type 2 diabetes mellitus: DIALOG Study results
    Sapozhnikova, I. E.
    Tarlovskaya, E. I.
    Sobolev, A. A.
    Rodygina, E. V.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2009, 8 (07): : 91 - 94
12345